Answers are grounded in this paper and cite their sources.
These results strongly indicate that MYC amplification is a prognostic marker of patients with early-stage lung ADCs.
No takes yet. Share an insight, caveat, or question.
Iwakawa et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: